Nasdaq: ARTV
Artiva Biotherapeutics insiders
The officers, directors and 10% owners of Artiva Biotherapeutics, Inc. who hold the most stock, valued at the live ARTV price.
$3.83
ARTV today +$60K (+1.59%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 3
- Their ARTV stock
- $89.0M
- Market value
- $189M
- Held by ranked insiders
- 47.0%
Insiders by value of ARTV holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | RA Capital Healthcare Fund LP | Director | 17,329,570 | $66.4M | 35.1% | Corporate |
| 2 | Yong-Jun Huh | Director | 4,567,412 | $17.5M | 9.24% | 5734th |
| 3 | Fred Aslan | Chief Executive Officer | 1,337,657 | $5.1M | 2.71% | 14212th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Artiva Biotherapeutics; see each profile for the filing.